Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joel Goldberg is active.

Publication


Featured researches published by Joel Goldberg.


Proceedings of the National Academy of Sciences of the United States of America | 2002

Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts

Thorsten Berg; Steven B. Cohen; Joel Desharnais; Corinna K Sonderegger; Daniel J Maslyar; Joel Goldberg; Dale L. Boger; Peter K. Vogt

Myc is a transcriptional regulator of the basic helix–loop–helix leucine zipper protein family. It has strong oncogenic potential, mutated or virally transduced forms of Myc induce lymphoid tumors in animals, and deregulated expression of Myc is associated with numerous types of human cancers. For its oncogenic activity, Myc must dimerize with the ubiquitously expressed basic helix–loop–helix leucine zipper protein Max. This requirement for dimerization may allow control of Myc activity with small molecules that interfere with Myc/Max dimerization. We have measured Myc/Max dimerization with fluorescence resonance energy transfer and have screened combinatorial chemical libraries for inhibitors of dimerization. Candidate inhibitors were isolated from a peptidomimetics library. Inhibition of Myc/Max interaction was validated by ELISA and electrophoretic mobility-shift assay. Two of the candidate inhibitors also interfere with Myc-induced oncogenic transformation in chicken embryo fibroblast cultures. Our work provides proof of principle for the identification of small molecule inhibitors of protein–protein interactions by using high-throughput screens of combinatorial chemical libraries.


Bioorganic & Medicinal Chemistry Letters | 2008

Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.

Jiacheng Zhou; Ashoke Bhattacharjee; Shili Chen; Yi Chen; Erin M. Duffy; Jay J. Farmer; Joel Goldberg; Roger Hanselmann; Joseph A. Ippolito; Rongliang Lou; Alia Orbin; Ayomi Oyelere; Joe Salvino; Dane M. Springer; Jennifer Tran; Deping Wang; Yusheng Wu; Graham Johnson

We have developed a first generation of hybrid sparsomycin-linezolid compounds into a new family of orally bioavailable biaryloxazolidinones that have activity against both linezolid-susceptible and -resistant gram-positive bacteria as well as the fastidious gram-negative bacteria Haemophilus influenzae and Moraxella catarrahalis. The convergent synthesis of these new compounds is detailed.


Bioorganic & Medicinal Chemistry Letters | 2008

Design at the atomic level : Generation of novel hybrid biaryloxazolidinones as promising new antibiotics

Jiacheng Zhou; Ashoke Bhattacharjee; Shili Chen; Yi Chen; Erin M. Duffy; Jay J. Farmer; Joel Goldberg; Roger Hanselmann; Joseph A. Ippolito; Rongliang Lou; Alia Orbin; Ayomi Oyelere; Joe Salvino; Dane M. Springer; Jennifer Tran; Deping Wang; Yusheng Wu; Graham Johnson

From the X-ray crystal structures of linezolid and the non-selective antibiotic sparsomycin, we have derived a new family of hybrid oxazolidinones. From this initial compound set we have developed a new biaryloxazolidinone scaffold that shows both potent antimicrobial activity as well as selective inhibition of ribosomal translation. The synthesis of these compounds is outlined.


Bioorganic & Medicinal Chemistry | 2001

Cytokine receptor dimerization and activation: prospects for small molecule agonists.

Dale L. Boger; Joel Goldberg

Ligand-induced dimerization of cell surface receptors has emerged as a general mechanism for the initiation of signal transduction. A number of therapeutically important receptor families are believed to be activated by this process. Recently available structural information, particularly for the erythropoietin receptor, has provided insight into the mechanism of receptor activation. These findings have also revealed important constraints on the nature of receptor-agonist complexes. The prospects of discovering small-molecule mimetics of such receptor agonists are discussed, including strategies which have led to the identification of a small number of peptide and non-peptide cytokine mimetics.


Helvetica Chimica Acta | 2000

Non-Amide-Based Combinatorial Libraries Derived fromN-Boc-Iminodiacetic Acid: Solution-Phase Synthesis of Piperazinone Libraries with Activity Against LEF-1/β-Catenin-Mediated Transcription

Dale L. Boger; Joel Goldberg; Shigeki Satoh; Yves Ambroise; Steven B. Cohen; Peter K. Vogt

The development of a solution-phase approach to the rapid, parallel synthesis of highly functionalized piperazinones in only four steps starting from N-Boc-iminodiacetic acid is detailed. The efforts represent the extension of the solution-phase synthesis of combinatorial libraries from N-Boc-iminodiacetic acid to non-amide-based libraries where simple liquid-liquid extractions are employed to purify all reaction products. This methodology was applied to the synthesis of a diverse 150-member library with substituents in three positions of the piperazinone core. Screening results from a luciferase reporter assay indicate that a number of library members are novel repressors of LEF-1/β-catenin-mediated transcription, and may be effective agents against colorectal tumors. Two secondary libraries (100 members each) designed from these lead structures were synthesized and screened, providing additional active agents and insight into key structure-activity relationships in the series. These compounds represent only the second class of small molecules which repress transcription of reporter genes containing LEF-1 responsive elements, and the first group not based on DNA minor-groove-binding agents.


Bioorganic & Medicinal Chemistry | 1998

Higher order iminodiacetic acid libraries for probing protein-protein interactions.

Dale L. Boger; Joel Goldberg; Weiqin Jiang; Wenying Chai; Pierre Ducray; Jae Kyoo Lee; Rachel S. Ozer; Carl-Magnus Andersson

Full details of the preparation of iminodiacetic acid diamide dimer (2040 compounds), trimer (560 compounds), and tetramer (1596 compounds) libraries by multistep convergent solution-phase synthesis for studying protein-protein interactions are provided. The libraries were assembled in a format providing small 8-10 compound mixtures and the deconvolution of many of the small mixtures to identify screening leads by resynthesis of the individual components have been conducted for 320 of the individual compounds to date. A representative example of the subsequent exploration of the structure-activity relationships for an identified receptor binding antagonist (200 additional individual compounds) and steps taken for potential elaboration to a receptor dimerization agonist are defined with preparation of representative linked dimers (70 compounds).


Bioorganic & Medicinal Chemistry Letters | 1996

A comparative study of the solvolysis reactivity, regioselectivity, and stereochemistry of the duocarmycin a and sa alkylation subunits

Dale L. Boger; Joel Goldberg; Jeffrey A. McKie

Abstract The comparative solvolysis reactivity, regioselectivity, and stereochemistry of N -BOC-DSA ( 4 ) and N -BOC-DA ( 5 ), simple derivatives of the DNA alkylation subunits of duocarmycin SA and A, are detailed. Most important of the observations is the substantially greater reactivity of 5 versus 4 (16x), the modest regioselectivity of both 4 (6.5-4:1) and 5 (1.5:1), and the establishment that the abnormal ring expansion solvolysis proceeds by S N 2 addition to the activated cyclopropane with clean inversion of the reacting center stereochemistry.


Bioorganic & Medicinal Chemistry Letters | 1998

Higher order iminodiacetic acid libraries for probing protein-protein interactions

Dale L. Boger; Pierre Ducray; Wenying Chai; Weiqin Jiang; Joel Goldberg

Higher order iminodiacetic acid diamide trimer (560 compounds) and tetramer libraries (1260 compounds) are described and were assembled in a convergent multistep solution-phase synthesis for use in studying protein-protein interactions.


Proceedings of the National Academy of Sciences of the United States of America | 2001

Disruption of matrix metalloproteinase 2 binding to integrin αvβ3 by an organic molecule inhibits angiogenesis and tumor growth in vivo

Steve Silletti; Torsten Kessler; Joel Goldberg; Dale L. Boger; David A. Cheresh


Chemical Reviews | 1997

CC-1065 and the Duocarmycins: Synthetic Studies.

Dale L. Boger; Christopher W. Boyce; Robert M. Garbaccio; Joel Goldberg

Collaboration


Dive into the Joel Goldberg's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dale L. Boger

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Weiqin Jiang

Scripps Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge